Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cassava Sciences Inc SAVA

Healthcare
Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on neuroscience. The Company's science is based on stabilizing, but not removing, a critical protein in the Alzheimer’s brain. Its scientific approach for the treatment of Alzheimer's disease seeks to simultaneously suppress both neurodegeneration and neuroinflammation. It has two biopharmaceutical assets under... see more

Recent & Breaking News (NDAQ:SAVA)

40 Biggest Movers From Yesterday

Benzinga.com  January 10, 2018

Mid-Afternoon Market Update: Pain Therapeutics Jumps On Clinical Study Data; Big 5 Sporting Goods Shares Plummet

Benzinga.com  January 9, 2018

40 Stocks Moving In Tuesday's Mid-Day Session

Benzinga.com  January 9, 2018

Pain Therapeutics Shares Double On Clinical Study Data

Benzinga.com  January 9, 2018

Mid-Morning Market Update: Markets Mostly Higher; Acuity Brands Profit Misses Views

Benzinga.com  January 9, 2018

Pain Therapeutics Reports Positive Top-line Results from Nasal Abuse Potential Study with REMOXY™

GlobeNewswire January 9, 2018

Pain Therapeutics Reports Positive Regulatory Meeting for REMOXY™

GlobeNewswire December 18, 2017

Pain Therapeutics Announces New Publication on Alzheimer’s Disease

GlobeNewswire December 14, 2017

Pain Therapeutics Reports Third Quarter 2017 Financial Results

GlobeNewswire November 1, 2017

40 Biggest Movers From Yesterday

Benzinga.com  October 31, 2017

Pain Therapeutics Announces Upcoming Meeting with FDA

GlobeNewswire October 30, 2017

22 Stocks To Watch After President Trump Declares Opioid Epidemic A National Health Emergency

Benzinga.com  October 26, 2017

40 Biggest Movers From Yesterday

Benzinga.com  October 25, 2017

Mid-Afternoon Market Update: Crude Oil Up Over 1%; Polaris Shares Surge On Upbeat Earnings

Benzinga.com  October 24, 2017

Tuesday's Biggest Stock Mover: Pain Therapeutics A Pleasure For Investors

Benzinga.com  October 24, 2017

33 Stocks Moving In Tuesday's Mid-Day Session

Benzinga.com  October 24, 2017

Mid-Day Market Update: Dow Rises 175 Points; Identiv Shares Plunge

Benzinga.com  October 24, 2017

Mid-Morning Market Update: Markets Open Higher; General Motors Profit Tops Expectations

Benzinga.com  October 24, 2017

Pain Therapeutics Announces Successful Phase I Clinical Study for PTI-125

GlobeNewswire October 24, 2017

12 Biggest Mid-Day Gainers For Monday

Benzinga.com  September 18, 2017